v3.26.1
Cover - shares
 6 Months Ended
Jun. 30, 2026
Aug. 14, 2026
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q2  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Document Transition Report false  
Entity File Number 001-42863  
Entity Registrant Name DRUGS MADE IN AMERICA ACQUISITION II CORP.  
Entity Central Index Key 0002040475  
Entity Incorporation, State or Country Code E9  
Entity Tax Identification Number 98-1815624  
Entity Address, Address Line One 420 Lexington Avenue  
Entity Address, Address Line Two Suite 1402  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10170  
City Area Code (917)  
Local Phone Number 982-4565  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   63,700,000
Units, each consisting of one Ordinary Share, par value $0.0001 per share, and one Right to receive one-tenth (1/10) of an Ordinary Share    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Ordinary Share, par value $0.0001 per share, and one Right to receive one-tenth (1/10) of an Ordinary Share  
Trading Symbol DMIIU  
Security Exchange Name NASDAQ  
Ordinary Shares    
Document Information [Line Items]    
Title of 12(b) Security Ordinary Shares  
Trading Symbol DMII  
Security Exchange Name NASDAQ  
Rights    
Document Information [Line Items]    
Title of 12(b) Security Rights  
Trading Symbol DMIIR  
Security Exchange Name NASDAQ